Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (651-660 of 666) with videos related to

Pageof 67
Sort By:
Circulation|December 20, 2013
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countriesFrank M Sacks, Michel P Hermans, Paola Fioretto, et al.
Plos Genetics|October 8, 2011
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRDCarsten A Böger, Mathias Gorski, Man Li, et al.
The New England Journal of Medicine|September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureMilton Packer, Stefan D Anker, Javed Butler, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2015
Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data AnalysisLayal Chaker, Christine Baumgartner, Wendy P J den Elzen, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Plos Genetics|June 28, 2012
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysisKrzysztof Kiryluk, Yifu Li, Simone Sanna-Cherchi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 8, 2016
Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data AnalysisLayal Chaker, Christine Baumgartner, Wendy P J den Elzen, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.
Clinical Kidney Journal|June 3, 2015
Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual ReportMaria Pippias, Vianda S Stel, José Maria Abad Diez, et al.
Cardiovascular Diabetology|May 7, 2026
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuumOliver Schnell, Arnav Agarwal, Michel Azizi, et al.
Pageof 67

Showing results (651-660 of 666) with videos related to

Sort By:
Pageof 67
Circulation|December 20, 2013
Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countriesFrank M Sacks, Michel P Hermans, Paola Fioretto, et al.
Plos Genetics|October 8, 2011
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRDCarsten A Böger, Mathias Gorski, Man Li, et al.
The New England Journal of Medicine|September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureMilton Packer, Stefan D Anker, Javed Butler, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2015
Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data AnalysisLayal Chaker, Christine Baumgartner, Wendy P J den Elzen, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Plos Genetics|June 28, 2012
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysisKrzysztof Kiryluk, Yifu Li, Simone Sanna-Cherchi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 8, 2016
Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data AnalysisLayal Chaker, Christine Baumgartner, Wendy P J den Elzen, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.
Clinical Kidney Journal|June 3, 2015
Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual ReportMaria Pippias, Vianda S Stel, José Maria Abad Diez, et al.
Cardiovascular Diabetology|May 7, 2026
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuumOliver Schnell, Arnav Agarwal, Michel Azizi, et al.
Pageof 67